FZD2 and prostate adenocarcinoma: In contrast, FZD2 expression was notably reduced in kidney chromophobe (KICH), kidney renal clear cell carcinoma (KIRC), prostate adenocarcinoma (PRAD), and thyroid carcinoma (THCA).